Unicycive Therapeutics, Inc. (UNCY) Financials
UNCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 64.4 million | 26.7 million |
| Dec. 31, 2025 | 49.1 million | 18.9 million |
| Sept. 30, 2025 | 50.6 million | 13.1 million |
| June 30, 2025 | 30.0 million | 13.6 million |
UNCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -6.2 million | 754000 |
| Dec. 31, 2025 | -8.0 million | 777000 |
| Sept. 30, 2025 | -6.0 million | 730000 |
| June 30, 2025 | -8.4 million | 571000 |
UNCY Net Income
No data available :(
UNCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 54.6 million | 217000 | 815000 |
| Dec. 31, 2025 | 41.3 million | - | 117000 |
| Sept. 30, 2025 | 42.7 million | - | 265000 |
| June 30, 2025 | 22.3 million | - | 409000 |
UNCY Shares Outstanding
UNCY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 8000 | 1.6 million | 6.8 million | - |
| Dec. 31, 2025 | - | 2.3 million | 5.0 million | - |
| Sept. 30, 2025 | 2000 | 3.0 million | 4.4 million | - |
| June 30, 2025 | 6000 | 1.8 million | 5.2 million | - |
UNCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 211000 |
| Dec. 31, 2025 | - | 151000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 138000 |
UNCY
Price: $7.17
52 week price:
Earnings Per Share: -2.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23619
Market Capitalization: 148.7 million